drug

AL002

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AL002: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

6Connections
0Hypotheses
1Analyses
6Outgoing
0Incoming
0Experiments
2Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💊 Drug Info
NameAL002
Key Genes/ProteinsTREM2

Pathway Diagram

flowchart TD
    AL002{"AL002"}
    TREM2(["TREM2"])
    microglia["microglia"]
    CEREBROSPINAL_FLUID("CEREBROSPINAL FLUID")

    AL002 -->|"expressed in"| TREM2
    AL002 -->|"activates"| microglia
    AL002 -.->|"inhibits"| microglia
    AL002 -->|"associated with"| TREM2
    AL002 -->|"associated with"| CEREBROSPINAL_FLUID

    style AL002 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px,color:#fff

Outgoing (6)

TargetRelationTypeStr
TREM2targetsgene0.90
microgliaactivatescell_type0.50
microgliainhibitscell_type0.50
CEREBROSPINAL FLUIDassociated_withconcept0.50
TREM2expressed_ingene0.50

Incoming (0)

SourceRelationTypeStr
No incoming edges

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

neurodegeneration | 2026-04-16 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (2)

Multi-agent debates referencing this entity

What is the current clinical trial landscape for AD therapeutics, and which mech

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

Is the amyloid concentration in AD clinical trials rational given lecanemab's ap

closed · Rounds: 4 · Score: 0.70 · 2026-04-16

Related Research

Hypotheses and analyses mentioning AL002 in their description or question text

No additional research found